TY  - GEN
AU  - Oelmann,E
AU  - Thomas,M
AU  - Serve,H
AU  - Kienast,J
AU  - Zühlsdorf,M
AU  - Mohr,M
AU  - Klinke,F
AU  - Dölken,G
AU  - Macha,H
AU  - Schmidt,E W
AU  - Berdel,W E
TI  - Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial
SN  - 0030-2414
PY  - 2002///1212
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Blood Cell Count
KW  - Carboplatin
KW  - Carcinoma, Small Cell
KW  - therapy
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Etoposide
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Hematologic Diseases
KW  - chemically induced
KW  - Hematopoietic Stem Cells
KW  - physiology
KW  - Humans
KW  - Ifosfamide
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000065473
ER  -